Why the study?
Does the TTK Chitra heart valve provide comparable hemodynamics and event-free survival to other prosthetic valves in patients requiring valve replacement?
Observational (n=200)
No
Does the TTK Chitra heart valve provide comparable hemodynamics and event-free survival to other prosthetic valves in patients requiring valve replacement?
Answers are grounded in this paper and cite their sources.
The TTK Chitra heart valve demonstrates comparable hemodynamic performance, mortality, and morbidity to other commonly used prosthetic valves at 4 years.
BACKGROUND: The TTK Chitra heart valve has been developed and widely used in India. This study aimed to evaluate its hemodynamics, complications, and event-free survival in comparison with other commonly used prosthetic valves. The role of color Doppler echocardiography in the follow-up of patients with prosthetic valves was also studied. PATIENTS AND METHODS: Two hundred patients underwent 249 valve replacements (122 mitral, 29 aortic, 49 both). Total follow-up was 451 patient-years. RESULTS: There were 18 late deaths (3.98% ± 0.92% per patient-year). One mitral valve replacement patient (0.36% ± 0.36% per patient-year) developed valve thrombosis. Two aortic valve replacement patients (2.74% ± 1.91% per patient-year), 2 double-valve replacement patients (1.95% ± 1.36% per patient-year) and 3 mitral valve replacement patients (1.08% ± 0.62% per patient-year) developed embolic complications. Freedom from all valve related mortality and morbidity at 4 years was 86% ± 4% for mitral valve replacement, 56% ± 10% for double-valve replacement, and 89% ± 6% for aortic valve replacement. The average peak gradient, mean gradient, and average peak velocity for the aortic and mitral positions were found to be comparable to those of other commonly used valves. CONCLUSION: The performance of this valve in terms of hemodynamic complications, mortality, and morbidity is comparable to other valves in common use. Hemodynamic gradients are more reproducible than effective orifice area, hence more beneficial for follow-up.
No takes yet. Share an insight, caveat, or question.
Malhotra et al. (2014) conducted an observational in Heart valve replacement (n=200). TTK Chitra heart valve vs. Other commonly used prosthetic valves was evaluated on Hemodynamics, complications, and event-free survival.
Synapse has enriched 10 related papers. Consider them for comparative context: